Podcasts about Antimicrobial resistance

In the last decade, there have been major changes in the approach of the treatment of pneumonia, in particular, with the availability of new diagnostic tools. Additionally, new drugs have been approved for the treatment of pneumonia. We discuss the approach to the management of pneumonia with a person who has spent most of his professional career working on this topic. Topics discussed: Definitions and nomenclature of pneumonia and evolution of these terms Changes in the diagnosis of pneumonia Ttherapeutic changes and future approaches for the treatment of pneumonia. Guest: Daniel M Musher, M.D. Links: ASM and IDSA launch the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) in 2026 This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal.  Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.

Send us a textDr. Michael Osterholm, PhD, MPH ( https://www.cidrap.umn.edu/michael-t-osterholm-phd-mph ) is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the Director of the Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, a professor in the Technological Leadership Institute, College of Science and Engineering, and an adjunct professor in the Medical School, all at the University of Minnesota. Dr. Osterholm is also a member of the National Academy of Medicine (NAM) and the Council of Foreign Relations. In June 2005 Dr. Osterholm was appointed by Michael Leavitt, Secretary of the Department of Health and Human Services (HHS), to the newly established National Science Advisory Board on Biosecurity. In July 2008, he was named to the University of Minnesota Academic Health Center's Academy of Excellence in Health Research. In October 2008, he was appointed to the World Economic Forum Working Group on Pandemics.Dr. Osterholm is an internationally recognized expert in infectious disease epidemiology and is the author of more than 300 papers and abstracts, including 20 book chapters, and New York Times best-selling 2017 book, Deadliest Enemy: Our War Against Killer Germs ( https://www.amazon.com/Deadliest-Enemy-Against-Killer-Germs/dp/0316343692 ).Dr. Osterholm's new book will be coming out in September, 2025, entitled The Big One: How We Must Prepare for Future Deadly Pandemics ( https://www.amazon.com/Big-One-Prepare-World-Altering-Pandemics-ebook/dp/B0C1G5BHG3 ).Dr. Osterholm has received numerous honors for his work, including an honorary doctorate from Luther College; the Pump Handle Award, CSTE; the Charles C. Shepard Science Award, CDC; the Harvey W. Wiley Medal, FDA; the Squibb Award, IDSA; Distinguished University Teaching Professor, Environmental Health Sciences, School of Public Health, UMN; and the Wade Hampton Frost Leadership Award, American Public Health Association. He also has been the recipient of six major research awards from the NIH and the CDC.Dr. Osterholm received his PhD and MS in Environmental Health, and MPH in Epidemiology, from the University of Minnesota. #MichaelOsterholm #InfectiousDisease #CenterForInfectiousDiseaseResearchAndPolicy #CIDRAP #PublicHealth #AntimicrobialStewardship #VaccineIntegrityProject #AntimicrobialResistance #MinnesotaDepartmentOfHealth #Epidemiologist #ToxicShockSyndrome #FoodborneIllness #Hepatitis #Biodefense #Countermeasures #ChronicWastingDisease #Preparedness #Policy #Surveillance #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

Send us a textPlastic is everywhere. So are drug-resistant microbes.What happens when the two team up?A raft of new studies show that bacteria can grow well on plastics, especially on microplastics. Other studies show just how widespread microplastics are – they are found in every ocean and sea tested so far. The most startling studies show these tiny bits of plastics can also build up in the human body, including in the liver and brain.Science is done piece by piece, study by study, with no single study painting the whole picture. Now a team at Boston University has added one piece to the puzzle, with a study demonstrating that drug-resistant bacteria grow well on microplastics.Neila Gross, a PhD candidate at BU, helped lead the research. Her team confirmed that E. coli bacteria form mats known as biofilms especially well on microplastics. The team found that antibiotic-resistant bacteria grew better when they were grown on microplastics.This raises a specter of billions of tiny pieces of plastic spreading drug-resistant bacteria around the world and being ingested and breathed in by animals from shellfish to marine mammals and, likely, people.Listen as Neila chats with One World, One Health host Maggie Fox about how this happens and what it might mean for the spread of antimicrobial resistance.

In the second episode of our miniseries on infectious disease diagnostics, Jonathan is joined by molecular epidemiologist Rodney Rohde, Regents' Professor at Texas State University, USA. Together, they explore diagnostic innovations in the fight against antimicrobial resistance, gaps in zoonotic disease detection, and the persistent challenge of vaccine hesitancy. Timestamps: 00:00 – Introduction 01:45 – Breakthroughs in molecular diagnostics 08:30 – Diagnostic tools to combat superbugs 14:18 – Can bacteriophages replace antibiotics? 19:04 – Controlling rabies and hantavirus 28:33 – Diagnostic successes and failures from COVID-19 35:22 – How do we address vaccine hesitancy? 44:10 – Preparing for the next pandemic 47:03 – Rohde's three wishes for healthcare

Send us an inquiry through a text message here!Welcome to another episode of The Veterinary Roundtable! In this episode, the ladies discuss the challenges of treating patients at a higher elevation, a handful of My Pets Wellness clinics closing overnight, keeping antimicrobial resistance in mind when treating patients, and more!Do you have a question, story, or inquiry for The Veterinary Roundtable? Send us a text from the link above, ask us on any social media platform, or email theveterinaryroundtable@gmail.com!Episodes of The Veterinary Roundtable are on all podcast services along with video form on YouTube!Instagram: https://tinyurl.com/2h27xnfuTikTok: https://tinyurl.com/m8f62ameYouTube: https://tinyurl.com/48njfywdTIMESTAMPSIntro 00:00Pits And Peaks 04:34Tails From The Trenches 11:32My Pets Wellness Closes All Vet Clinics Overnight 16:50New Immunotherapy Treatment May Delay Metastasis In Dogs With Osteosarcoma 21:18Case Collections 23:36Listener Loves Intranasal Bordetella 31:10Treating Patients At A Higher Elevation 34:00Keep Antimicrobial Resistance In Mind When Treating Patients 37:44Outro 44:28

Friday, April 4th, 2025Today, the acting Inspector General for the Department of Defense has launched an investigation into Pete Hegseth's Signal chat messages; the Senate has voted to rescind some of Trump's tariffs which caused the third biggest stock market crash in modern history; federal prosecutors have dropped the charges against the guy Nancy Mace says assaulted her; massive layoffs at the FDA include scientists working on bird flu and pet food safety; Judge Boasberg held a hearing in the contempt proceedings in the Alien Enemies Act case; and Allison delivers your Good News.Guest: Mayor Karen BassMayor Bass Applauds FEMA's Extension of Deadline for No-Cost Debris Removal ProgramWildfire Recovery Resources - LA CityResources Centers Available For Those Impacted by L.A. WildfiresEARTH DAY LA - April 25Mayor Karen BassMayor Karen Bass (@mayor.lacity.gov) — BlueskyGuest: John FugelsangTell Me Everything — John FugelsangThe John Fugelsang PodcastSiriusXM ProgressThank You, Pique LifeGet 20% off on the Radiant Skin Duo, plus a FREE starter kit at Piquelife.com/dailybeans.Stories:Pentagon watchdog launches probe of Hegseth Signal messages | CNN PoliticsSenate Votes to Rescind Some Trump Tariffs, With G.O.P. Support | The New York TimesTrump contradicts aides, talking points on purpose of global tariffs | The Washington PostVeterinarians working on bird flu, pet food safety are fired in HHS purge | The Washington PostCharge dropped against foster advocate accused of assaulting Rep. Nancy Mace | The Washington PostGood Trouble:Hands off 2025 is tomorrow! Go to HandsOff2025.com to find the rally nearest you, put on your comfy shoes, stay hydrated and KNOW YOUR RIGHTS. Know Your Rights | Protesters' Rights | ACLU From The Good NewsShit Show (Instrumental) | YouTubeItalian Government -Citizenship by descent (iure sanguinis)Public Service Loan Forgiveness (PSLF) Federal workers - feel free to email me at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen.Share your Good News or Good Trouble:https://www.dailybeanspod.com/good/ Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Substack|Muellershewrote, Twitter|@MuellerSheWrote, Threads|@muellershewrote, TikTok|@muellershewrote, IG|muellershewrote, BlueSky|@muellershewroteDana GoldbergTwitter|@DGComedy, IG|dgcomedy, facebook|dgcomedy, IG|dgcomedy, danagoldberg.com, BlueSky|@dgcomedyHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

In this episode of the EMJ Podcast, Jonathan Sackier sits down with Jose Alexander, Clinical Microbiologist and Director of Microbiology at AdventHealth Orlando, to explore the cutting edge of infectious disease diagnostics. From next-generation sequencing to rapid tests for brain-eating amoeba, Alexander shares insights into the latest innovations shaping the field, the fight against antimicrobial resistance, and the future of microbiology diagnostics. Timestamps: 00:00 – Introduction 03:55 – Alexander's introduction to microbiology 05:42 – Developing a rapid test for a brain-eating amoeba 09:40 – Where is this amoeba found? 12:13 – Next-generation sequencing in infectious disease 14:36 – Streptococcus pneumoniae serotype/genotype service 17:06 – Vaccine hesitancy 19:03 – Antimicrobial resistance 22:02 – The discovery of a novel variant of Klebsiella pneumoniae 24:32 – The clinical use of bacteriophages 27:01 – The future of the field 28:41 – Alexander's three wishes for healthcare

Matters Microbial #84: Detecting Pathogens — and Worse — in Wastewater March 27, 2025 Today, Dr. Rachel Poretsky, Associate Professor of Biological Sciences at the University of Illinois Chicago joins the #QualityQuorum to discuss how examining wastewater (and related water) can give insights into the presence of pathogen antimicrobial resistance genes and even microbial ecology. Host: Mark O. Martin Guest: Rachel Poretsky Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A link to demonstrate the wonders of the Marine Biological Laboratories' Microbial Diversity course, which I know for a fact is life changing. Recommended by David Ranada, an article about water bottles and microbes.   An essay about the Chicago River and cholera, which led to the necessity of effective waste water treatment. An overview of the complexities of waste water treatment.  Here is a video on that topic.   An essay by Carl Zimmer about the microbial ecology of lakes…and human beings. How “recreational water quality” is determined. An article describing the microbiota associated with human biological waste with an amusing name (scroll down). How qPCR can be used to determine the prevalence of specific microbes. A recent article from Dr. Poretsky's research group, investigating how antimicrobial resistance genes can move through a hospital waste water system. A link to the Bacterial-Viral Bioinformatics Resource Center, for which Dr. Poretsky is a Principle Investigator. The Illinois state wastewater surveillance dashboard.  Fascinating! A Discovery Channel documentary on virus hunting and surveillance that includes Dr. Poretsky. Dr. Poretsky's faculty webpage. Dr. Poretsky's webpage for her research group. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Send us a textDr. Marianne Holm, MD, Ph.D. is Vice President of the Infectious Diseases Program area, at the Novo Nordisk Foundation ( https://novonordiskfonden.dk/en/ ) where she is responsible for supporting the development and implementation of new strategic initiatives and research programs, and developing partnerships that contribute to the global visibility and impact of the foundation's activities within Infectious Diseases, and this responsibility includes supporting multiple cross disciplinary initiatives in Antimicrobial Resistance (AMR).Dr. Holm is a medical doctor and epidemiologist, who previously led the department of epidemiology and public health research at the International Vaccine Institute (IVI) in Seoul, where she was responsible for the coordination and implementation of several large development programs funded by the Fleming Fund, working with local governments and healthcare institutions to build capacity in AMR surveillance in low- and middle- income countries in the Asian region. Prior to joining IVI in 2018, Dr. Holm worked for 4 years at the School of Public Health at the University of Hong Kong working in the health services research unit coordinating the School's evidence based practice education program.Dr. Holm has been a member of the coordination group of the WHO Technical Advisory Group and Coordination Group on Vaccines and AMR. She is also a member of the Global Burden of Disease (GBD) Collaborator Network as well as the Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC) network.Dr. Holm received her MD and Ph.D. from University of Copenhagen and Master of Science (MSc), Epidemiology, London School of Hygiene and Tropical Medicine, U. of London.IMPORTANT EPISODE LINK - Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) - https://gcgh.grandchallenges.org/challenge/innovations-gram-negative-antibiotic-discovery The Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) is tripartite initiative of the Novo Nordisk Foundation, the Bill & Melinda Gates Foundation and Wellcome Trust, that will focus on discovery of direct-acting small-molecule antibiotics with broad-spectrum activity against Enterobacteriaceae (a large family of Gram-negative bacteria that includes Salmonella, Escherichia coli, Shigella and Klebsiella), with Klebsiella spp. selected as an initial targeted pathogen. Klebsiella organisms can lead to a wide range of disease states, notably pneumonia, urinary tract infections, sepsis, meningitis, diarrhea, peritonitis and soft tissue infections. The program aims to address the lack of novel antibiotics for gram-negative bacteria and the public health threat posed by antimicrobial resistance (AMR).#NovoNordiskFoundation #GramNegativeAntibioticDiscoveryInnovator #BillAndMelindaGatesFoundation #WellcomeTrust #AMR #AntimicrobialResistance #Enterobacteriaceae #Klebsiella #Salmonella #EscherichiaColi #Shigella #InfectiousDiseases #MarianneHolm #Vaccines #MultidrugEffluxPumps #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this edition of The Naked Scientists, Antimicrobial Resistance, or AMR, is going under our microscope. What is it, how does it happen, what's the scale of the threat, and how can we fight back? Like this podcast? Please help us by supporting the Naked Scientists

"I have wondered if heart attacks could be an issue because it is a shock to the body when you walk into a cold shower. I don't know. When you did those plunges, did you sort of slowly go in, or did you go in all at once because it's easier that way?" -Alexandra Paul "No. I go all in, all at once. For me, if I do the gradual process—where I'm just dipping a toe in, literally just dipping a toe in—the feedback that my mind will give me is: ‘Danger, danger, danger. Do not do this.' So I do it because I want to override that fear response and the danger signals that my brain is telling me. And I'm grateful. I'm like, ‘Thank you so much for those signals. You're working. Excellent. And we're going to go and do this.' So I will literally just go right in…" -Jason Wrobel In this episode, Alexandra and Jason dive into the hot and cold of wellness—literally, exploring the pros and cons of cold plunging, from its potential benefits for mental health, inflammation, and immunity to the risks you should know before taking the plunge. They also tackle the rise of superbugs, antibiotic resistance, what's causing it, how it can impact you, and how you can protect yourself. Plus, Alexandra shares her personal experiences with antibiotics, her best advice for restoring gut health, and her go-to tips for staying healthy and happy! Podcast sponsor: Vedge Vegan Collagen: vedgenutrition.com – use code S4G for 30% off your order. - https://www.vedgenutrition.com/ What we discuss in this episode: The history and evolution of antibiotic use. How to protect yourself in hospital settings. The link between animal protein consumption and antibiotic resistance. What cold plunging involves and how it works. The power of setting boundaries.  The importance of staying present and grounded. How volunteering can enrich your life. Resources: Health effects of voluntary exposure to cold water – a continuing subject of debate - PMC Association of Diet and Antimicrobial Resistance in Healthy U.S. Adults - PubMed   Click the link below to support the FISCAL Act https://switch4good.org/fiscal-act/ Share the website and get your resources here https://kidsandmilk.org/ Send us a voice message and ask a question. We want to hear from you! Switch4Good.org/podcast Dairy-Free Swaps Guide: Easy Anti-Inflammatory Meals, Recipes, and Tips https://switch4good.org/dairy-free-swaps-guide SUPPORT SWITCH4GOOD https://switch4good.org/support-us/ ★☆★ JOIN OUR PRIVATE FACEBOOK GROUP ★☆★  https://www.facebook.com/groups/podcastchat ★☆★ SWITCH4GOOD WEBSITE ★☆★ https://switch4good.org/ ★☆★ ONLINE STORE ★☆★ https://shop.switch4good.org/shop/ ★☆★ FOLLOW US ON INSTAGRAM ★☆★ https://www.instagram.com/Switch4Good/ ★☆★ LIKE US ON FACEBOOK ★☆★ https://www.facebook.com/Switch4Good/ ★☆★ FOLLOW US ON TWITTER ★☆★ https://twitter.com/Switch4GoodOrg ★☆★ AMAZON STORE ★☆★ https://www.amazon.com/shop/switch4good ★☆★ DOWNLOAD THE ABILLION APP ★☆★ https://app.abillion.com/users/switch4good

States rush to ban food dyes ahead of federal action; NIH cuts funds for studies of vaccine hesitancy; RFK Jr. ridiculed for urging vitamin A for measles; Brain tumors in firefighters show signature of chemical exposure; Unpacking the causes of numbness, tingling and pain in lower extremities; Class-action lawsuit targets Depo-Provera as contributor to meningioma brain tumors; Uncovering the mystery of Trump's 20+ pound weight loss; Microplastics implicated in spiraling antibiotic resistance.

Send us a textDr. Noel Gahamanyi, Ph.D. ( https://scholar.google.com/citations?user=HWW6M_wAAAAJ&hl=en ) is Division Manager, National Reference Laboratory at the Rwanda Biomedical Centre (RBC).Rwanda Biomedical Centre ( RBC - https://rbc.gov.rw/ ) is the nation's central health implementation agency which strives to improve the health of the Rwandan population by providing high quality, affordable and sustainable health care services, accomplished through the implementation of preventative, rehabilitative, and curative health interventions. RBC conducts scientific research, provides diagnostics services, and implements innovative health interventions to protect the nation against diseases and other health threats.Dr. Gahamanyi is a Microbiologist with interest in Bacterial pathogens and their drug-resistance potentials and has served as a Lecturer of Microbiology in the School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda.Dr. Gahamanyi received his Ph.D. from Sokoine University of Agriculture, Tanzania. Dr. Gahamanyi also holds a MSc in Microbiology from Jain University (India) and BSc in Biotechnology from the former National University of Rwanda. Before embarking on Ph.D. journey, Dr. Gahamanyi served as a Lecturer of Microbiology-related courses at Catholic University of Rwanda where he also served as Head of Biology Department and then as the Vice-dean of the Faculty of Science and Technology. In Research, Dr. Gahamanyi has nine published papers and one book chapter all related to Microbiology. Five of these are indexed in PubMed. He also served as a reviewer for six international journals. Dr. Gahamanyi is a member of the American Society for Microbiology (ASM) and the Young East African Health Research Scientists (YEARS) forum affiliated to the East African Health Research Commission. Dr. Gahamanyi received a number of awards including the Best Sokoine University of Agriculture (SUA) Postgraduate student Research Award for the academic year 2020-21 and the First-class with gold medal after completing MSc in Microbiology at top of the class (2013).Important Episode Link - Students Against Superbugs (SAS) Africa - https://www.studentsagainstsuperbugs.org/ #NoelGahamanyi #Microbiology #RwandaBiomedicalCentre #NationalReferenceLaboratory #AntimicrobialResistance #AMR #AntimicrobialStewardship #Campylobacter #Marburg #ZoonoticSpillover #Ethnobotany #Ethnopharmacology #Phytochemistry #NaturalProducts   #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

John Maytham speaks with Nazir Ismail, Head of Clinical Microbiology and Infectious Diseases at Wits University, about an extraordinary new discovery in the immune system that could revolutionize the fight against antibiotic-resistant infections. Scientists have found that the proteasome, previously known for recycling proteins, has an unexpected ability to produce bacteria-killing chemicals.See omnystudio.com/listener for privacy information.

Dr. Don and Professor Ben talk about the risks of letting a parrot stir you coffee with a spoon every day. Dr. Don - risky ☣️ Professor Ben - not risky

A recent report from the Engineering Research Visioning Alliance emphasizes the urgent need for engineering-directed research to mitigate the growing threat of antimicrobial resistance. Anita Shukla, PhD, a professor of engineering at Brown University, discusses its findings with JAMA Medical News Associate Managing Editor Kate Schweitzer and presents several key opportunities. Related Content: Five Engineering Advancements That May Help Solve the Growing Threat of Antimicrobial Resistance

Dr. John Sia, Infectious Diseases Fellow at the Morsani College of Medicine, shares a grand rounds presentation on the national One Health Framework for addressing zoonotic diseases in the U.S. Dr. Sia introduces a clinical case involving a patient exposed to a zoonotic infection. Next, he covers different zoonotic pathogens and their vectors and focuses on Bartonella, Bacillus anthracis, and Brucella. Next, he describes how the One Health initiative helps teams of medical clinicians, scientists, and veterinarians to address disease threats in a collaborative fashion. After brief descriptions of two more cases, Dr. Sia closes with further examples of how the One Health Initiative is beneficial in combating antimicrobial resistance and connecting human, animal, and environmental health.

  What if the lessons learned from a conflict zone could transform military medicine worldwide? Join us as we promise to reveal groundbreaking insights into combat casualty care with John Quinn, MD, MPH, PhD, EMT-P, a leading voice in Emergency Medicine and Combat Casualty Care. Dr. Quinn shares his experiences and pivotal lessons from the war in Ukraine, providing an in-depth look at how military medical operations have evolved in response to the challenges faced in high-stakes environments. Gain valuable knowledge on damage control, resuscitation, and the strategic decisions made from the point of injury to more advanced medical roles.    The complexities of combat medicine are not for the faint-hearted. In this compelling episode, we confront the realities of triage and care under fire, with medical personnel often working without senior guidance amidst the chaos of large-scale combat. Our discussion sheds light on the critical importance of Tactical Combat Casualty Care and the intricate decisions around tourniquet use when resources are stretched thin. Dr. Quinn emphasizes the skills required to manage such intense scenarios, ensuring listeners understand the vital balance between operational readiness and effective medical intervention.     Handling pain management and blood supply logistics in conflict zones is no small feat. We explore the intricate challenges of ensuring adequate supplies and effective pain medication, particularly in the context of Ukraine's ongoing conflict. Dr. Quinn delves into the necessity of a robust supply of universal donor blood and the pressing need for improved clinical governance to support pre-hospital blood transfusion capabilities. The episode addresses the pressing issue of antimicrobial resistance and antibiotics' critical role in these settings, highlighting the need for structured guidance and oversight to navigate the complexities of treating diverse patient populations. Chapter Timestamps 00:02 Military Medicine and Operational Readiness 09:30 Combat Medicine and Triage Challenges 14:08 Challenges in Pre-Hospital Pain Management 17:43 Combat Medic Challenges and Solutions   Chapters with Summaries (00:02) Military Medicine and Operational Readiness This chapter explores the insights and experiences shared by Dr. John Quinn, the lead author of a pivotal article on pre-hospital lessons from the war in Ukraine, focusing on damage control, resuscitation, and surgery from point of injury to role two. Dr. Quinn, with a background as a paramedic and emergency medicine physician, recounts his involvement in Ukraine since 2014, highlighting the evolution of military medical operations up to the large-scale invasion by Russia. We discuss the collaborative effort behind the article, featuring a diverse team of experts, including traumatology surgeons, paramedics, and academic figures, all working to enhance combat casualty care. Dr. Quinn emphasizes the importance of incorporating Ukrainian academics' insights and using NATO's terminology for lessons learned, providing a comprehensive look at the on-the-ground experiences and challenges faced in providing timely and effective medical care in conflict zones.   (09:30) Combat Medicine and Triage Challenges This chapter addresses the complex challenges faced by medical personnel in large-scale combat operations, particularly in the context of the ongoing conflict involving Russian forces. We explore how medical workers, including international volunteers, are specifically targeted, necessitating unique approaches to operational security, communication, and personal protective equipment. The discussion emphasizes the importance of tactical combat casualty care, especially in making critical triage decisions without the guidance of senior clinical decision-makers. With an overwhelming number of patients and limited evacuation capabilities, medical personnel must navigate the intricacies of tourniquet use, balancing between preventative application and conversion to pressure dressings as per TCCC protocols. The chapter highlights the essential skills required to manage care under fire and the need for timely assessment by qualified providers to reduce morbidity and enhance force effectiveness in the battlefield.   (14:08) Challenges in Pre-Hospital Pain Management This chapter addresses the challenges and intricacies of pain management and blood supply logistics in conflict zones, particularly focusing on the context of Ukraine. We explore the inadequacies of certain medications like Nalbuphine, which can complicate effective pain management when transitioning patients to higher levels of care. The importance of having access to more effective drugs such as ketamine and fentanyl is emphasized, although logistical challenges in their distribution are acknowledged. Additionally, we highlight the critical need for an ample supply of universal donor blood and low-titer O blood products during large-scale combat operations. The chapter underscores the logistical hurdles in ensuring these supplies are available before they spoil and discusses the inadequacy of traditional walking blood banks in high-casualty scenarios, advocating for improved clinical governance to enable broader pre-hospital blood transfusion capabilities.   (17:43) Combat Medic Challenges and Solutions This chapter highlights the critical importance of antibiotics in deployed medical settings, emphasizing the challenges of antimicrobial resistance, particularly in Ukraine. We explore the need for a structured antimicrobial guidance system, informed by biogram data, to prevent inappropriate dosing and resistance. The discussion extends to the complexities of treating diverse age groups, including elderly and pediatric patients, who may have additional medical conditions or require specialized care. Additionally, we stress the significance of clinical governance in ensuring that medical personnel, whether affiliated with NGOs or the military, operate under proper oversight and standards. Finally, we identify the top three priorities for improvement: ensuring an unlimited supply of low-titer universal donor blood, enhancing training and clinical decision-making, and leveraging data for effective medical logistics and planning.   Take Home Messages: Evolving Military Medical Practices: The podcast delves into the evolution of military medical operations in Ukraine, highlighting the lessons learned from the ongoing conflict. It emphasizes the importance of adapting medical practices to the realities of modern warfare, particularly in large-scale conflicts where traditional medical procedures may not suffice. Challenges in Battlefield Medicine: Listeners are exposed to the myriad challenges faced by medical personnel in combat zones, including the complexities of tactical combat casualty care and the necessity for rapid, autonomous decision-making under fire. The episode underscores the need for enhanced training and preparation to handle these high-pressure situations effectively. Pain Management and Medical Logistics: The discussion reveals significant hurdles in managing pain and logistics in conflict zones, with specific reference to Ukraine's current crisis. It stresses the need for reliable access to effective medications and blood supplies, highlighting the logistical challenges that can impact patient outcomes. Antimicrobial Resistance and Clinical Governance: The episode sheds light on the critical role of antibiotics in deployed medical settings and the growing concern of antimicrobial resistance. It advocates for structured guidance systems and emphasizes the importance of clinical governance to ensure high standards of care are maintained, especially when relying on NGOs and international volunteers. Data-Driven Medical Improvements: The conversation calls for the collection and analysis of medical data to enhance military medical practices. It stresses the importance of leveraging lessons learned from current conflicts to refine medical logistics, decision-making processes, and training, ensuring better preparedness for future challenges.   Episode Keywords: Military Medicine, Operational Readiness, Combat Medicine, Triage, Ukraine Conflict, Russian Invasion, Damage Control, Resuscitation, Surgery, Battlefield, Tactical Combat Casualty Care, Tourniquets, Pressure Dressings, Pain Management, Logistical Hurdles, Antimicrobial Resistance, Clinical Governance, Medical Logistics, Training, Data Analysis   Hashtags: #CombatMedicine #UkraineConflict #BattlefieldHealthcare #MilitaryMedicine #EmergencyCare #TacticalCombatCasualtyCare #FrontlineMedicine #WarfareInnovations #ConflictZoneMedicine #DrJohnQuinn   Article Citation: Quinn J et al. Prehospital Lessons From the War in Ukraine: Damage Control Resuscitation and Surgery Experiences From Point of Injury to Role 2. Mil Med. 2024 Jan 23;189(1-2):17-29. doi: 10.1093/milmed/usad253. PMID: 37647607.   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast  

Avec Charlotte Brives, anthropologue. Quand on tombe malade, on sait désormais qu’il ne faut pas “automatiquement” prendre des antibiotiques. Plus on en prend souvent, plus les bactéries y deviennent résistantes et moins les traitements antibiotiques ultérieurs seront efficaces. Aujourd'hui les bactéries résistantes tuent plus de personnes dans le monde que le sida ou le paludisme.  Charlotte Brives est anthropologue au CNRS et dans son dernier livre, “Face à l’antibiorésistance, Une écologie politique des microbes” (Amsterdam, 2022), elle revient sur l’histoire des antibiotiques, sur leur usage massif, bien au-delà de la sphère de la médecine humaine et sur la manière dont ils ont profondément influencé notre économie et notre société. A travers son récit, c’est toute notre perception de la maladie et des microbes qui s’en trouve chamboulée.  Comment va-t-on pouvoir se soigner si les antibiotiques ne fonctionnent plus ? Doit-on chercher à éradiquer les maladies à tout prix ? Faut-il arrêter les antibiotiques ? Un épisode des Idées Larges avec Charlotte Brives, anthropologue. Références : - Anna Tsing, “Proliférations”, Wildproject, 2022- Donna Haraway,  « Anthropocene, Capitalocene, Plantationocene, Chthulucene: Making Kin », Environmental Humanities, vol. 6, no 1- Michelle Murphy, « Chemical Infrastructures of the Saint Clair River », in S. Boudia et N. Jas (dir.), Toxicants, Health and Regulation since 1945, Pickering and Chatto, 2013- Jason Moore, “Capitalism in the Web of Life”, Verso, 2015- Clare Chandler, « Current Accounts of Antimicrobial Resistance: Stabilisation, Individualisation and Antibiotics as Infrastructure », Palgrave Communications, no 5, 2019- Dame Sally Davies, “Infections and the Rise of Antimicrobial Resistance”, 2013- Emily Martin, “Flexible Bodies”, Beacon Press, 1995- Evelyn Fox Keller, “Le Siècle du gène”, Gallimard, 2003- Hannah Landecker, “Culturing Life: How Cells Became Technologies”,Harvard University Press, 2006 Archives sonores : - TF1 - JT -  01/04/2013- Pulsations, avec la participation de France Télévisions/AlloDocteurs.fr - Bernard Faroux - Abus d'antibiotiques - une catastrophe annoncée - 2016- Office national de radiodiffusion télévision française (ORTF)/INA - Maurice Beuchey - Flash sur le passé - 1965- TV5 Monde Info - En Chine, un "hotel à cochons" - 30 octobre 2022- Sky News - Antibiotic resistance "could kill us before climate change" - 29 août 2019- F2 - Caisse Nationale d'Assurance Maladie - Publicite "Les antibiotiques c'est pas automoatique" - Assurance Maladie - 2002- Victoria Denys - Virus bacteriophage - 2022- RTS - 36,9 - Phagothérapie: les virus tueurs de bactéries - 2018- Warner Bros. Pictures, Conundrum Entertainment - Bradley Thomas, Peter Farrelly, Bobby Farrelly, Zak Penn, Dennis Edwards - Osmosis Jones - 2001- INA - 19-20 edition nationale France 3 - 16/03/2020 Musique Générique :« TRAHISON » Musique de Pascal Arbez-Nicolas © Delabel Editions, Artiste : VITALIC,(P) 2005 Citizen Records under Different Recording licence ISRC : BEP010400190,Avec l’aimable autorisation de [PIAS] et Delabel Editions.  Episode vidéo publié le 10 mai 2024 sur arte.tv Autrice Laura Raim Réalisateur Jean Baptiste Mihout Son Nicolas Régent Montage Pauline Chabauty Mixage et sound design Jean-Marc Thurier Une co-production UPIAN Margaux Missika, Alexandre Brachet, Auriane Meilhon, Emma Le Jeune, Karolina Mikos avec l'aide de Nancy-Wangue Moussissa ARTE France Unité société et culture

Send us a textOn this episode of the CMAJ Podcast, Dr. Mojola Omole and Dr. Blair Bigham explore the growing challenge of antimicrobial resistance and how shorter courses of antibiotics are reshaping prescribing practices. The conversation builds on insights from the CMAJ practice article “Five things to know about shorter courses of antibiotics” co-authored by Dr. Maria Ivankovic, an emergency physician at St. Joseph's Health Centre in Toronto.Dr. Ivankovic explains why shorter courses of antibiotics are as effective as longer ones for many common infections and how this approach can reduce the risk of antimicrobial resistance and adverse effects for patients. She highlights key conditions with strong evidence for shorter durations and discusses practical strategies for implementing these changes in practice.Dr. Lynora Saxinger, an infectious diseases specialist and professor of medicine at the University of Alberta, broadens the discussion by examining the current state of antimicrobial resistance in Canada and globally. She explores the drivers of resistance, including unnecessary and inappropriate antibiotic use. Dr. Saxinger introduces the concept of the antibiotic footprint as an analogue to the carbon footprint, encouraging physicians to consider the collective impact of their prescribing decisions.This episode provides actionable advice for physicians looking to balance patient care with stewardship practices, helping to preserve the effectiveness of antibiotics for future generations.To learn more about exciting physician careers from our sponsor, Vancouver Coastal Health, visit vch.ca/jobyouwantJoin us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Happy Friday! We're bringing you a bonus episode this Friday featuring an interview from our Times Radio afternoon show (2-4pm, Monday to Thursday). Jane and Fi speak to Dame Sally Davies, she's the UK Special Envoy on Antimicrobial Resistance and Former Chief Medical Officer for England former Chief Scientific Adviser at the Department of Health. She joins them to discuss superbugs, the state of the NHS and the future of antimicrobial resistance. The next book club pick has been announced! Eight Months on Ghazzah Street is by Hilary Mantel. If you want to contact the show to ask a question and get involved in the conversation then please email us: janeandfi@times.radioFollow us on Instagram! @janeandfiPodcast Producer: Eve SalusburyExecutive Producer: Rosie Cutler Hosted on Acast. See acast.com/privacy for more information.

Matters Microbial #73: Seeing the Microbiome January 8, 2025 Today, Dr. Travis Wiles, Assistant Professor of Molecular Biology and Biochemistry at the University of California, Irvine, joins the #QualityQuorum to discuss the work he and his research group have done to visualize the changing dynamics of the gut microbiome—including bacteriophages residing there.  Host: Mark O. Martin Guest: Travis Wiles Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode Dr Anne Estes' academic website is found here, along with her blog, and her social media link on Bluesky.  So many interesting ideas! Transgenic zebrafish as pets are called GLOfish. Use of zebrafish as a model system for developmental biology. An article exploring the effects of the microbiome on gnotobiotic (“germ free”) zebrafish. An essay on both lytic and lysogenic bacteriophages. An essay describing how bacteriophage interact with the gut microbiota.  One of my former undergraduate research students, Dr. Danielle Campbell, works in this area! An article suggesting that bacteriophage do in fact interact with eukaryotic cells. The concept of phage conversion:  how some bacteriophages carry bacterial genes, including toxin genes. An article about bacteriophages and bacterial evolution. An article about the study of the zebrafish gut microbiome. An article about research with zebrafish and Mycobacterium.  The article discussed in this episode by Dr. Wiles' group: “Phollow: Visualizing Gut Bacteriophage Transmission within Microbial Communities and Living Animals .”    Dr. Wiles' academic website. Dr. Wiles' very colorful and interesting laboratory group website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Welcome to Buffalo HealthCast, the official podcast of the University at Buffalo's School of Public Health and Health Professions

L'efficacité des antibiotiques hypothéquée par les résistances, favorisées par un emploi excessif d'anti-bactériens. En 2019, l'antibiorésistance aurait entraîné la mort de 1,27 millions de personnes dans le monde, selon une étude du Global Research on Antimicrobial Resistance des universités d'Oxford et de Washington. Est-ce certaines résistances aux antibiotiques sont propres à certaines bactéries ou maladies ? En terme de résistance, y-a- t'il d'autres critères, géographiques par exemple, qui entrent en jeu ? Est-ce qu'n peut évaluer en chiffres l'impact de l'antibiorésistance à l'échelle mondiale en terme de vies perdues ?      Sophie Gay, docteur en Biologie et coordinatrice de programmes internationaux portant sur la résistance aux antibiotiques au sein de l'Agence Nationale de la Recherche (ANR)Retrouvez l'émission dans son intégralité iciLes enjeux des pénuries d'antibiotiques et de l'antibiorésistance

When bacteria, viruses, fungi, and parasites change over time and no longer respond to medicines, it makes infections harder to treat. This increases the risk of disease spread, severe illness, and death.  Antimicrobial resistance (AMR) leads to deaths, high health treatment costs, and economic and livelihood losses. Jennifer Cohn, Director, Global Access at Global Antibiotic R&D Partnership (GARDP), joins Ray Suarez to talk about the threat of AMR, and how to prevent it. Guest: Dr. Jennifer Cohn, Director, Global Access at Global Antibiotic R&D Partnership (GARDP) Host:   Ray Suarez If you appreciate this episode and want to support the work we do, please consider making a donation to Commonwealth Club World Affairs. We cannot do this work without your help. Thank you.

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.  

The topic of climate change can engender a ‘doom and gloom' narrative, as many climate and health consequences are already manifesting. Our host, Dr. Navaneeth Narayanan is joined by two ID physicians passionate about climate change and sustainable clinical practice, Dr. Shreya Doshi (Washington DC, US) and Dr. Laura Jung (Leipzig, Germany). Together they discuss new trends in infectious diseases observed in clinical practice as a direct consequence of climate change, including how tropical diseases are not so tropical anymore. They also outline ways individual clinicians and hospitals can be more sustainable and offer additional resources for the listeners (see below).  This episode was edited by Kathryn Hostettler and peer reviewed by Dr. Loora Grünvald of the University of Tartu, Estonia.  LiteratureMora C et al. Nat Clim Chang (2022). doi: 10.1038/s41558-022-01426-1Doshi S et al. J Pediatric Infect Dis Soc (2023). doi: 10.1093/jpids/piae029Hofmeister RJ et al. OFID (2024). doi: 10.1093/ofid/ofae368 Judson SD et al. OFID (2024). doi: 10.1093/ofid/ofae691Jung L et al. Lancet Planet Health (2023). 10.1016/S2542-5196(22)00253-4UN General Assembly High-Level Meeting on antimicrobial resistance 2024 https://www.who.int/news-room/events/detail/2024/09/26/default-calendar/un-general-assembly-high-level-meeting-on-antimicrobial-resistance-2024  Additional resourcesLancet countdown on health and climate change  https://www.thelancet.com/countdown-health-climateMedicine for a changing planet https://www.medicineforachangingplanet.org/Rx for climate https://www.rxforclimate.org/Chapters

In this episode Dhineli Perera speaks to John Turnidge, who leads the national surveillance program for Antimicrobial Use and Resistance in Australia. They discuss the significant impact of the pandemic on reducing antibiotic use in the community, and how this benefit can be sustained and improved on. Read the full article by John and his co-authors, Carolyn Hullick and Kim Stewart, in Australian Prescriber.

Wastewater surveillance is a powerful epidemiological tool that “mirrors our life,” and has gained wide attention in recent years due to its application during the COVID-19 pandemic. The hosts this week, Drs. Navaneeth Narayanan and Emily McDonald, are joined by two wastewater surveillance experts, Dr. Nasreen Hassoun-Kheir of Geneva University Hospitals, a WHO Collaborating Centre on antimicrobial resistance (AMR), as well as Professor David Graham of Newcastle University, United Kingdom, to discuss how this surveillance method—as well as a multidisciplinary approach—are central to understanding community health, infection control and pandemic preparedness. This episode was edited by Kathryn Hostettler and peer reviewed by Dr. James Donnelly of the Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland.LiteratureUN Environment Programme (UNEP), Bracing for superbugs (2023) https://www.unep.org/resources/superbugs/environmental-action  Hassoun-Kheir N, et al. EMBRACE-WATERS statement (2021). doi:10.1016/j.onehlt.2021.100339 Hassoun-Kheir N, et al. Systematic review (2020). doi: 10.1016/j.scitotenv.2020.140804 Trask JD, et al. (1942). https://pmc.ncbi.nlm.nih.gov/articles/PMC2135222/Chapters (00:00) - Introduction (03:03) - Icebreaker question (08:33) - What is wastewater surveillance (WWS)? (12:47) - How does WWS relate to infection surveillance? (16:57) - WWS & pandemic preparedness (21:09) - Is the data accessible to the public? (25:10) - WWS uses in healthcare settings & mass health: what it can and cannot answer (43:00) - What's next for WWS: experts' picks (48:33) - Take-home messages

In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year's theme ‘Educate. Advocate. Act now'. Joining the conversation is Elias Revonta, Founder and CEO, Orcason Medical, who shares his vision for tackling AMR through groundbreaking medical technology. Orcason Medical is pioneering point-of-care devices for ear, nose and throat conditions to address the overprescription of antibiotics—a vital measure in the fight against AMR. A little more on GOLD's guest… Elias Revonta is the Founder and CEO, Orcason Medical, where he is supported by a strong background in the medical device industry – spanning over 20 years in various leadership roles from sales to product development. He is passionate about transforming and democratising healthcare with modern and easy-to-use diagnostic tools that serve all demographics. With a mission to combat the rise of AMR, his goal is to protect the power of antibiotics and improve the lives of millions of patients by enabling smarter, safer healthcare solutions.

In this episode, FAO urges all its members and partners to join the Global Alliance Against Hunger and Poverty at the G20 Summit; together with Azerbaijan's government, FAO launches the Baku Harmoniya Climate Initiative for Farmers at the UN Climate Summit; and FAO presents an IT Platform to track Antimicrobial Resistance.   Producer: Ruki Inoshita, Heriberto Araujo, Flora Trouilloud Presenter: Ruki Inoshita Sound: Eric Deleu Editorial supervision: Blagoje Grujic ©FAO/Fernando Reyes

 For this episode of Microbe Talk Clare is joined by Dr Sanjay Patel, a paediatric infectious disease and immunology consultant at Southampton Children's Hospital and the National Clinical Advisor for Paediatric Antimicrobial Stewardship at NHS England. Clare and Sanjay discuss paediatric AMR, why it's often overlooked and how Sanjay and his colleagues from clinical, research and policy backgrounds are taking action.  If you'd like to learn more about research into antimicrobial resistance in neonates, take a look at this paper in Journal of Medical Microbiology.You can find details of how to get involved with Knocking Out AMR here.The resources and initiatives Sanjay mentioned are below:  National empirical antimicrobial guidelines The common infection clinical pathways, the IV to oral switch decision aid The common infection paediatric pathways Music: Inspiring Science Technology - Comma Media from Pixabay

In this episode of the Micro Binfie podcast, host Andrew Page is live from the 10th Microbial Bioinformatics Hackathon in Bethesda, Maryland. He sits down with David Mahoney, a PhD student from Dalhousie University in Halifax, Nova Scotia. David shares his research on characterizing antimicrobial resistance (AMR) genes and their transfer within metagenomes, focusing on metagenomic assembly graphs. They delve into David's background in food safety microbiology and his interest in the public health implications of genomics. He explains his exciting work on analyzing how AMR genes transfer across different environments, such as food production plants and clinical settings, using both new and existing data from Canada's Genomics Research and Development Initiative. David also highlights his use of innovative methods like assembly graphs and graph-based approaches to uncover AMR gene flow and lateral gene transfers, including the potential of machine learning techniques such as graph convolutional neural networks.

To receive a free written summary of the podcast, sign up for our newsletter here.   (Or copy paste this link in your browser: https://vigneshdevraj.com/#:~:text=of%20future%20generations.-,SUBSCRIBE,-TO%20RECEIVED%20A)  The discovery of penicillin in the 1940s revolutionized medicine, saving millions of lives and establishing the foundation for modern healthcare. However, the misuse and overuse of antibiotics have led to an alarming global crisis: Antimicrobial Resistance (AMR). This man-made disaster threatens the future of healthcare, making once-treatable infections deadly again. Addressing AMR requires awareness, collective action, and a shift in how we use antibiotics.  In this episode, Dr Vignesh and Dr Ranga Reddy Burri give a breakdown of the crisis, its causes, and the urgent need for sustainable solutions. Key topics discussed in this episode are: AMR: The Silent Pandemic  The Silent Drives of AMR Antibiotics: The two-edged Sword  AMR in the West and in India Need to build an new ecosystem Timestamps 00:00 - 07:09: The Silent Pandemic approaching us 07:09 - 15:16: What is AMR?  15:16 - 27:15: What's accelerating AMR? 27:15 - 31:47: Government dealing with AMR 31:47 - 39:57: The way forward with antibiotics  39:57 - 46:26: Build an new ecosystem 46:26 - 58:50: AMR in the West vs India 58:50 - 01:02:11: Is it too late to reverse AMR? 01:02:11- 01:06:43: Conclusion Dr Vignesh Devraj  If you are interested in doing one on one Ayurvedic consultation with Dr Vignesh Devraj please find the details in this link:  https://calendly.com/drvignesh/30-minute-session-with-dr-vignesh-devraj-md-ay-ist If you are economically challenged, please use the form provided to request a free Ayurvedic consultation here.  (or copy paste this in your browser:  https://docs.google.com/forms/d/e/1FAIpQLSd29nHcrC1RssR-6WAqWCWQWKKJo7nGcEm8ITEl2-ErcnfVEg/viewform ) BALANCE THE MIGHTY VATA - ONLINE COURSE NOW AVAILABLE  What makes Ayurveda unique in its treatment approach is its practical wisdom on the concept of Vata. Vata is responsible for Prana - the life energy, nervous system - the master panel of our body, and our emotions. In Ayurveda, it is mentioned that controlling Vata is the most difficult part of healing and recovery.  Recently I have recorded a workshop on - Balancing The Mighty Vata which has over 6 hrs of content, with notes filled with practical inputs that can be integrated into our life.  You can access this at https://drvignesh.teachable.com/ For further information about Dr Vignesh Devraj, kindly visit www.vigneshdevraj.com and www.sitaramretreat.com  Instagram -  @sitarambeachretreat | @vigneshdevraj Twitter - @VigneshDevraj We truly hope you are enjoying our content. Want to help us shape and grow this show faster? Leave your review and subscribe to the podcast, so you'll never miss out on any new episodes. Thanks for your support. Disclaimer: - The content of the podcast episodes is not intended to be a substitute for professional medical procedures, consultations, diagnosis, or treatment in any manner. We strongly do not recommend using the content of these episodes as medical advice for any medical conditions for you, others, or for treating your patients.

Send us a textChildren under five years old are fragile. They're more vulnerable than adults to malaria, pneumonia, diarrhea, and other infections. A growing number of these infections that sicken and kill children are resistant to the drugs developed to treat them – a phenomenon known as antimicrobial resistance, or AMR.AMR is a big killer. Nearly five million deaths are caused in part by drug-resistant infections each year. While the percentage of children killed by these infections has fallen greatly since 1990, hundreds of thousands still die. Vaccines can help.  So can infection control measures as simple as handwashing routines. Patients everywhere also need to be able to get the best antibiotics to treat their infections at the right time. These infections are often more difficult to treat in low- and middle-income countries in part because they have fewer staff to clean and to care for patients, less access to effective antibiotics, and crowded neonatal units, which can worsen the spread of germs. In a special edition of One World, One Health recorded for AMR Awareness Week, we spoke with Dr. Heather Finlayson, a Pediatric Infectious Diseases Specialist at Stellenbosch University's Tygerberg Hospital in Cape Town, South Africa.Listen as she tells us about her struggles fighting drug-resistant superbugs in the youngest of children.

Antimicrobial resistance, or AMR, is centre stage in the Saudi Arabian city of Jeddah this week, where top health officials have been attending the Fourth Global High-Level Ministerial Meeting on these so-called superbugs which have become increasingly resistant to existing strains of antibiotics.Threatening to make the medicines on which we depend less effective, AMR is already responsible for killing 1.3 million people every year.Attending the conference, Hanan Balkhy – a physician who is one of the World Health Organization's senior officials leading the charge against AMR – told UN News's Ezzat El-Ferri that “awareness is one of the global action plan pillars” which need to be strengthened. 

रोगाणुरोधी प्रतिरोध (Antimicrobial Resistance) पर की विशाल चुनौती से निपटने उपायों पर चर्चा के लिए सउदी अरब के जेद्दाह शहर में एक मंत्रिस्तरीय सम्मेलन आयोजित हो रहा है. यूएन न्यूज़ हिन्दी की अंशु शर्मा ने संयुक्त राष्ट्र खाद्य एवं कृषि संगठन (FAO) के भारत कार्यालय में एंटीमाइक्रोबियल प्रतिरोध विशेषज्ञ, डॉक्टर ज्योति मिसरी से AMR समस्या की गम्भीरता व जेद्दाह सम्मेलन से अपेक्षाओं पर बात की.

Are we entering a new era in the fight against antimicrobial resistance (AMR)? Listen to our latest podcast series to hear how sustainable access to effective antibiotics and diagnostic development may impact the battle against AMR.

In this edition of The Naked Scientists: The UK detects its first case of the new Mpox variant, but some are saying what took us so long; also the discovery of a lost city beneath the jungle canopy in Mexico; and the robots helping Cambridge scientists understand the evolution of fish... Like this podcast? Please help us by supporting the Naked Scientists

Drs. Cesar Arias (@SuperBugDoc) and Katie Barber join Dr. Julie Ann Justo (@julie_justo) to discuss what is hot-off-the-presses for gram-positive bacterial infections and it's a total party vibe! They review the latest news for recent and ongoing clinical trials (DOTS, DISRUPT, and SNAP trials), discuss hope for novel clinical tests of the cefazolin inoculum effect in staphylococci, and explore the fascinating changes in virulence and potential therapeutic options for the most challenging enterococci. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About X: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp References Climate Change and Antimicrobial Resistance. Editors in Conversation Podcast. American Society for Microbiology. Oct 2023. Is More Better? The Role of Combination Therapy for MRSA. Breakpoints Podcast Episode #30. Society of Infectious Diseases Pharmacists. Turner NA, et al. DOTS: Dalbavancin as an Option for Treatment of Staphylococcus aureus Bacteremia. ESCMID Global 2024. April 2024. NCT04775953. Real-world dalbavancin observational cohort: Rebold N, et al. Infect Dis Ther. 2024 Mar;13(3):565-579. doi: 10.1007/s40121-024-00933-2. PMID: 38427289. Exebacase DISRUPT trial : Fowler VG Jr, et al. Clin Infect Dis. 2024 Jun 14;78(6):1473-1481. doi: 10.1093/cid/ciae043. PMID: 38297916. @snap_trial tweet of Breaking News. Aug 2024. Investigator Resources for the SNAP trial. Sept 2024: https://www.snaptrial.com.au/for-investigators#interim Cefazolin inoculum effect on mortality in MSSA bacteremia : Miller WR, et al. Open Forum Infect Dis. 2018 May 23;5(6):ofy123. doi: 10.1093/ofid/ofy123. PMID: 29977970. Prevalence of cefazolin inoculum effect in MSSA and modified rapid nitrocefin test for detection: Carvajal LP, et al. Antimicrob Agents Chemother. 2024 Sep 30:e0089824. doi: 10.1128/aac.00898-24. PMID: 39345182. LiaX as surrogate for cell envelope stress in Enterococus faecium: Axell-House DB, et al. Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0106923. doi: 10.1128/aac.01069-23. PMID: 38289081. Shorter is better for uncomplicated streptococcal bacteremia: Clutter DS, et al. Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0022024. doi: 10.1128/aac.00220-24. PMID: 38975753. Short vs. long antibiotic duration in Streptococcus pneumoniae bacteremia: Crotty M, et al. Open Forum Infect Dis. 2024 Aug 30;11(9):ofae478. doi: 10.1093/ofid/ofae478. PMID: 39257675. This podcast is powered by Pinecast.

Dr. Tekisha Everette, Executive Vice President at Trust For America's Health, outlines the six priorities of the new Trust For America's Health Blueprint Report; Andrea Schon, National Account Manager for VMSG Dashboard, previews ASTHO's upcoming performance management system vendor showcase; and ASTHO's HAI roadmap will help you understand Healthcare-Associated Infections and Antimicrobial Resistance programs. Trust for America's Health Web Page: Pathway to a Healthier America: A Blueprint for Strengthening Public Health for the Next Administration and Congress ASTHO Web Page: Vendor Showcase – Performance Management Systems ASTHO Web Page: HAI Roadmap ASTHO Web Page: Stay Informed  

In this episode of Life Sciences 360, host Harsh Thakkar sits down with Marc Sheetz, Associate Dean of Research at Midwestern University's College of Pharmacy, to discuss the growing concern of antimicrobial resistance and the field of pharmacometrics. Marc sheds light on how pharmacometrics is shaping the future of medicine by using predictive models to personalize dosing, making drug treatments more effective while reducing toxicity. This episode dives deep into the intersection of pharmacometrics, AI, and machine learning, revealing how the future of patient care and treatment is rapidly evolving. Marc also shares insights from his current research in the infectious disease space, including his work with pediatric ICU patients.Chapters:00:00 Introduction00:03 Antibiotic Toxicity and Population Models01:02 The Importance of Antibiotics and Public Health Challenges01:22 Introduction to Pharmacometric Science03:12 Using Data in Medicine for Future Predictions06:01 Tailoring Drug Dosages for Individuals09:36 The Global Variation in Drug Dosages and Challenges14:44 The Future of Personalized Medicine and Precision Dosing21:39 The Intersection of AI, Machine Learning, and Pharmacometrics26:35 The Role of Technology in Medicine30:01 How Dosing Software and AI Are Enhancing Patient Care36:54 Innovation and Research Trends in Medicine- Connect with Marc Sheetz on Twitter: (https://twitter.com/IDPharmacometrics)  - Learn more about Midwestern University: (https://www.midwestern.edu)  - Follow Life Sciences 360 on LinkedIn (https://www.linkedin.com/company/life-sciences-360)--- Subscribe to our podcast for more insights on life sciences: 

Dr. Johan Melendez, a Johns Hopkins School of Medicine Assistant Professor, discusses STI antimicrobial resistance (AMR) and why Neisseria gonorrhoea is resistant, AMR diagnostic options such as point-of-care assays, and his work on evaluating AMR in resource-limited settings with National STD Curriculum Podcast Editor Dr. Meena Ramchandani.  View episode transcript at www.std.uw.edu.This podcast is dedicated to an STD [sexually transmitted disease] review for health care professionals who are interested in remaining up-to-date on the diagnosis, management, and prevention of STDs. Editor and host Dr. Meena Ramchandani is an Assistant Professor of Medicine at the University of Washington (UW) and Program Director of the UW Infectious Diseases Fellowship Program. 

Canadian farm groups have voiced major concerns regarding a private member’s bill that has quietly reached the second reading stage in the Senate. Bill C-293, introduced in 2022 by Liberal MP and noted vegan, Nate Erskine-Smith, is one of many private member’s bills that have gained traction under the Liberal minority government. The bill would... Read More

There are an awful lot of things to worry about in the world. Are “superbugs” among them? That is, how worried should we be that bacteria will develop resistance to our best antibiotics, meaning infections will run rampant and even basic surgery is out of the question?In this episode of The Studies Show, Tom and Stuart wash their hands and then dig in to the evidence on the coming antimicrobial crisis. Exactly how many deaths can we expect from untreatable resistant infections? Turns out the question is, ahem, resistant to easy answers. (Sorry).The Studies Show is brought to you by Works in Progress magazine. Every issue, every article, gives you a new perspective on a topic you thought you knew about, or a totally new topic to think about. In their most recent issue, you can read about inflation, ancient scrolls and AI, genetic engineering, and the evolution of coffee. We're grateful that they support the podcast; you can read their whole site for free at worksinprogress.co.Show notes* Andreas Bäumler on “the coming microbial crisis”* Possible source for how many people used to die in surgery * BMJ article on the evidence (or lack of) showing that completing an antibiotic course is necessary* Satirical post on how the length of a course is calculated* Our World In Data on how many people die from cancer each year* UK Government review of antimicrobial resistance (from 2014), giving the 10m figure. * More mentions of 10m here (NHS), and here (Guardian)* 2016 paper in PLOS Medicine criticising the modelling that led to the 10m figure* September 2024 paper in the Lancet with a more up-to-date calculation* EU report on how MRSA rates dropped* Article on the wildly successful UK attempt to cut MRSA infections* Study on how many antibiotics are in the clinical “pipeline”* Thread on studies showing that using antibiotics prophylactically cut child mortality in sub-Sarahan Africa by 14%Credits* The Studies Show is produced by Julian Mayers at Yada Yada Productions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.thestudiesshowpod.com/subscribe

Ramanan Laxminarayan is the founder and president of the One Health Trust, Director of the WHO Collaborating Center on Antimicrobial Resistance in New Delhi, India, and an Affiliate Professor at the University of Washington, Seattle, WA. He is the lead author of The Lancet's May 2024 series on Sustainable Access to Antibiotics. He joins Gavin and Jessamy to discuss how big of a problem AMR currently is and will be, what is being done, and what needs to be done.Read the Series here:https://www.thelancet.com/series/antibiotic-resistance?dgcid=buzzsprout_tlv_podcast_generic_lancetSend us your feedback!Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Leo hapa makao makuu ya Umoja wa Mataifa, kando ya mjadala mkuu wa UNGA79, viongozi wanakutana kwenye Mkutano wa Ngazi ya Juu ukimulika usugu wa viuavijiumbe maradhi, Antimicrobial Resistance, kwa kiswahili ikiitwa pia UVIDA, au Usugu wa Vimelea dhidi ya Dawa. Katika taarifa ya Pamoja iluyotolewa kwenye mkutno huo na mashirika ya Umoja wa Mataifa lile la afya duniani WHO, la mazingira UNEP, la chakula  na kilimo FAO na shirika la afya ya Wanyama duniani WOAH, usugu wa viua vijiumbe maradhi unahusika moja kwa moja na vifo milioni 1.3 na kuchangia vingine milioni 5 kila mwaka.Unaweza kujiuliza ni nini na kwa nini ni muhimu wakutane? Bosco Cosmas, wa Idhaa ya Kiswahili ya Umoja wa Mataifa amezungumza na Profesa Mshiriki wa Vimelea Vya Magonjwa katika Chuo Kikuu cha Sayans iza Afya Bugando, mkoani Mwanza, Kaskazini Magharibi mwa Tanzania.

Most people don't even think twice when they get an infection. Much of the time, the best treatment is simple: fluids and rest. Bacterial infections can be treated with antibiotics – a quick course of pills, maybe a week or 10 days, and you're done.But the rise of drug-resistant pathogens is changing that. These germs (viruses, bacteria, parasites, and fungi) have developed the ability to survive even the strongest of antimicrobial drugs. This phenomenon is known as antimicrobial resistance or AMR.Drug-resistant infections just from bacteria play a role in close to five million deaths a year. That's five million people. One of those people was a promising, intelligent young woman named Mallory Smith. An honors student, athlete, and writer, Mallory was just 25 when she died. She had cystic fibrosis, but what killed her was a superbug infection she had caught when she was 12. This happened even after getting a lung transplant.Now Mallory's mother, Diane Shader Smith, is telling her daughter's story to the world. She wants people to know about Mallory and about the threat of antimicrobial resistance. She's also collecting the stories of other people who have been made victims of this growing threat to humanity because she understands the difference stories make in ensuring people understand the gravity of antimicrobial resistance.Listen as she tells One World, One Health about her daughter's struggles and about her own hopes for the future of humanity.

Heteroresistance is a phenomenon that has been well characterized for many years. However, we are only now starting to understand its mechanistic basis. Indeed, the manner how bacteria respond to antibiotics is complex and phenomena such as persistance, tolerance may be overlapping with heteroresistance. Furthermore, heteroresistance seems to be common in real clinical scenarios and understanding its basis is likely to open new avenues on how we deploy antibacterials in clinical practice., Today, we have experts in the field to discuss this important topic. Watch this episode at https://youtu.be/qcIcyn1bIHU. Topics discussed: The differences between heteroresistance, persistence and tolerance The mechanistic basis both in Gram-positive and Gram-negative bacteria The clinical implication and diagnosis of heteroresistance Guests: David Weiss, Ph.D. Professor of Medicine and Director Center for Antimicrobial Resistance, Emory University School Of Medicine, Atlanta. GA. William Miller, MD. Assistant Professor of Medicine, Houston Methodist, Houston, TX and Weill Cornell Medical College, New York, NY. Links: Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal.  Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up. Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.  Subscribe to the podcast at https://asm.org/eic.

Rosemary Bartel had no idea her life was going to take a turn when she went to a hospital near her home in Chilton, Wisconsin in the United States for standard knee replacement surgery – her second such operation. She was ready to work hard to recover and return to her busy job at her Roman Catholic diocese. But Rosie developed an all-too-common infection known as MRSA—methicillin-resistant Staphylococcus aureus. It's one of the best-known examples of antimicrobial-resistant microbes, often called superbugs. The United Nations is devoting a high-level meeting to the problem in September 2024 in the hopes of getting nations to do more to fight antimicrobial resistance or AMR.Now, 15 years later, Rosie has had her leg and hip amputated because the infection got into her bones. She has suffered numerous other infections, been in comas, lost her job, lost her health insurance, and lost most of the life she had loved.“I will probably be paying hospital bills for the rest of my life,” Rosie tells One World, One Health. Rosie is one of the luckier victims of AMR. She's still alive. Five million people a year die from complications caused by these drug-resistant germs. Now, Rosie shares her story as widely as she can as part of the Patient Family Partners Network, a group of patient advocates working to improve healthcare in the United States, and the Leapfrog Group, a nonprofit patient safety advocacy organization. She's also written a book, “Rosie's Story,” about her experience with this devastating and unending infection. Listen as Rosie describes what happened to her and what she hopes to do to help stop it from happening to others